APA (7th ed.) Citation

Rodriguez-Freixinos, V., Lheureux, S., Mandilaras, V., Clarke, B., Dhani, N., Mackay, H., . . . Oza, A. (2019). Impact of somatic molecular profiling on clinical trial outcomes in rare epithelial gynecologic cancer patients. Gynecologic Oncology, 153(2), 304. https://doi.org/10.1016/j.ygyno.2019.02.005

Chicago Style (17th ed.) Citation

Rodriguez-Freixinos, V., et al. "Impact of Somatic Molecular Profiling on Clinical Trial Outcomes in Rare Epithelial Gynecologic Cancer Patients." Gynecologic Oncology 153, no. 2 (2019): 304. https://doi.org/10.1016/j.ygyno.2019.02.005.

MLA (9th ed.) Citation

Rodriguez-Freixinos, V., et al. "Impact of Somatic Molecular Profiling on Clinical Trial Outcomes in Rare Epithelial Gynecologic Cancer Patients." Gynecologic Oncology, vol. 153, no. 2, 2019, p. 304, https://doi.org/10.1016/j.ygyno.2019.02.005.